In-depth analyses, practical guides and news on medical device regulation. For demanding QA/RA professionals.
The digital omnibus (Regulation (EU) 2026/1744) pushes high-risk AI Act obligations for medical device AI to 2 August 2028. What already applies.
Classes I, IIa, IIb and III: the 22 rules of MDR Annex VIII, the implementing rules, special cases and what the class changes for CE marking.
Cybersecurity requirements for medical devices: MDR Annex I, MDCG 2019-16, IEC 81001-5-1, NIS 2 and FDA section 524B (SBOM, vulnerability management).
What a medical device's technical documentation must contain under MDR Annexes II and III: description, design, GSPR, risk, V&V and post-market surveillance.
Since 2 February 2026, the QMSR (21 CFR 820) incorporates ISO 13485:2016 by reference. FDA-specific requirements, inspections and records now open to review.
ISO 14971:2019 step by step: plan, risk analysis, evaluation and control, overall residual risk, review, production and post-production, and the MDR link.
How to CE mark a medical device under the MDR: qualification, class, quality system, technical documentation, notified body, EU declaration, EUDAMED.
MDSAP: one quality system audit recognised by the United States, Canada, Brazil, Australia and Japan. Audit cycle, nonconformity grading and limits.
Harmonised standards under the MDR and IVDR: Official Journal publication, presumption of conformity, revisions and common specifications.
MDR Articles 83 to 86 and Annex III: post-market surveillance system and plan, PMS report, PSUR by class, PMCF, trend reporting and vigilance.
How a medical device manufacturer should organise regulatory monitoring: sources to follow, frequency, log, impact analysis and proof for audits.
IVDR and Regulation (EU) 2024/1860: class D by 31/12/2027, C by 31/12/2028, B and sterile A by 31/12/2029. Conditions to meet and action plan.
Role of the local materiovigilance officer and the biomedical engineer: hospital obligations, what to do when an FSCA hits your fleet, fleet monitoring.
Which sources to monitor, how often, and how to prove your regulatory monitoring in an ISO 13485 audit or to your notified body (MDR Article 10(9)).
Regulation (EU) 2017/745 in plain terms: scope, classes, PRRC, Annex I, technical documentation, clinical evaluation, PMS and 2027-2028 transition deadlines.
EUDAMED has been mandatory since 28 May 2026 for four modules: SRN, device registration, certificates, update deadlines and mistakes to avoid.
MDR Article 61 and Annex XIV: sufficient clinical data, equivalence, mandatory investigations, CER, PMCF, SSCP and MDCG 2020-5 to 2020-8 guidance.
MDR, IVDR, PRRC, EUDAMED, UDI, CER, PMCF, PSUR, MDSAP, QMSR: the 60 acronyms of medical device regulatory affairs and quality assurance.
MDR Rule 11 and MDCG 2019-11: when software is a medical device, how to classify it as class I, IIa, IIb or III, with examples and standards.
MDR (2017/745) or IVDR (2017/746)? Scope, classes I-III and A-D, clinical or performance evaluation, notified bodies, PMS and transition deadlines.
ISO 13485 audit: timeline from 6 months before to 90 days after, evidence to gather, typical questions by clause and how to answer nonconformities.
Who can be a PRRC under Article 15 of the MDR and IVDR: degree or 4 years' experience, five duties, external PRRC for SMEs, EUDAMED and penalties.
UDI-DI, UDI-PI, Basic UDI-DI, labelling deadlines by class and the EUDAMED modules mandatory since 28 May 2026: what manufacturers must do.
Vigilance under the MDR (Articles 87 to 92): serious incident definition, 2, 10 and 15-day deadlines, FSCA, trend reports, PSUR and competent authorities.
MedQara aggregates ANSM, FDA, EMA and more - AI summarizes and tells you what to do. Free account, no credit card.